Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Use "female pattern hair loss" term, finasteride may help, more research needed.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Cimetidine did not reduce hair growth in women with hirsutism.

Exercise and finasteride together improve ovary health in PCOS rats.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Most women with Polycystic Ovarian Disease have trouble getting pregnant due to hormonal imbalances, but lifestyle changes and certain drugs can help.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.